PL353732A1 - Zastosowanie inhibitorów IL-18Zastosowanie inhibitorów IL-18 - Google Patents

Zastosowanie inhibitorów IL-18Zastosowanie inhibitorów IL-18

Info

Publication number
PL353732A1
PL353732A1 PL00353732A PL35373200A PL353732A1 PL 353732 A1 PL353732 A1 PL 353732A1 PL 00353732 A PL00353732 A PL 00353732A PL 35373200 A PL35373200 A PL 35373200A PL 353732 A1 PL353732 A1 PL 353732A1
Authority
PL
Poland
Prior art keywords
inhibitors
interleukin
tumor metastasis
inhibit tumor
inhibit
Prior art date
Application number
PL00353732A
Other languages
English (en)
Other versions
PL202477B1 (pl
Inventor
CharlesDinarello Charles Dinarello
DanielaNovick Daniela Novick
MenachemRubinstein Menachem Rubinstein
Original Assignee
Yeda Research And Development Co.Ltd.Yeda Research And Development Co.Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co.Ltd.Yeda Research And Development Co.Ltd. filed Critical Yeda Research And Development Co.Ltd.Yeda Research And Development Co.Ltd.
Publication of PL353732A1 publication Critical patent/PL353732A1/pl
Publication of PL202477B1 publication Critical patent/PL202477B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL353732A 1999-07-22 2000-07-17 Zastosowanie inhibitorów działania IL-18 PL202477B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors

Publications (2)

Publication Number Publication Date
PL353732A1 true PL353732A1 (pl) 2003-12-01
PL202477B1 PL202477B1 (pl) 2009-06-30

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353732A PL202477B1 (pl) 1999-07-22 2000-07-17 Zastosowanie inhibitorów działania IL-18

Country Status (31)

Country Link
US (1) US7741276B2 (pl)
EP (1) EP1206274B1 (pl)
JP (1) JP4827352B2 (pl)
KR (1) KR100682219B1 (pl)
CN (1) CN1173736C (pl)
AR (1) AR024907A1 (pl)
AT (1) ATE363288T1 (pl)
AU (1) AU782478B2 (pl)
BG (1) BG65800B1 (pl)
BR (1) BR0012675A (pl)
CA (1) CA2380216C (pl)
CY (1) CY1107932T1 (pl)
CZ (1) CZ302114B6 (pl)
DE (2) DE1206274T1 (pl)
DK (1) DK1206274T3 (pl)
EA (1) EA005419B1 (pl)
EE (1) EE04838B1 (pl)
ES (1) ES2186596T3 (pl)
HK (1) HK1048248B (pl)
HU (1) HU228780B1 (pl)
IL (2) IL131047A0 (pl)
MX (1) MXPA02000838A (pl)
NO (1) NO329827B1 (pl)
NZ (1) NZ516535A (pl)
PL (1) PL202477B1 (pl)
PT (1) PT1206274E (pl)
SK (1) SK287522B6 (pl)
TR (1) TR200200169T2 (pl)
UA (1) UA73745C2 (pl)
WO (1) WO2001007480A2 (pl)
ZA (1) ZA200200390B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100951067B1 (ko) * 2000-02-10 2010-04-07 아보트 러보러터리즈 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고사용하는 방법
JP2004528010A (ja) 2000-10-11 2004-09-16 バイロン・セラピューティックス・インコーポレーテッド 免疫モジュレーションのための核酸およびポリペプチド
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
SI1425028T1 (sl) * 2001-05-16 2010-02-26 Yeda Res & Dev Uporaba inhibitorjev za il-18 za zdravljenje ali prepreäśevanje sepse
RU2225720C1 (ru) * 2002-08-12 2004-03-20 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана
EP1572291B1 (en) * 2002-10-08 2013-04-03 Ares Trading S.A. The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
AU2006254103B2 (en) 2005-06-03 2012-09-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
DK1891088T3 (da) 2005-06-10 2012-01-30 Ares Trading Sa Fremgangsmåde til rensning af et IL-18-bindende protein
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
US20250297018A1 (en) 2022-03-15 2025-09-25 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
WO2024148243A1 (en) 2023-01-06 2024-07-11 Lassen Therapeutics 1, Inc. Anti-il-18bp antibodies
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ299210A (en) * 1992-09-02 2000-08-25 Isis Pharmaceuticals Inc Treating diseases characterised by changes in intercellular adhesion molecules using coding sequences hybridizable with those encoding proteins involved in synthesis of such molecules
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
PL336464A1 (en) * 1997-03-18 2000-06-19 Basf Ag Method of and compositions for modulating reactivity in respect to corticosteroids i
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
NZ516535A (en) 2004-04-30
BRPI0012675B1 (pt) 2001-02-01
EA005419B1 (ru) 2005-02-24
HU228780B1 (en) 2013-05-28
BG65800B1 (bg) 2009-12-31
SK882002A3 (en) 2002-07-02
CZ2002195A3 (cs) 2002-06-12
ZA200200390B (en) 2003-04-30
PT1206274E (pt) 2007-07-06
CN1364086A (zh) 2002-08-14
AU782478B2 (en) 2005-08-04
JP4827352B2 (ja) 2011-11-30
DE60035049D1 (de) 2007-07-12
ES2186596T1 (es) 2003-05-16
NO20020153L (no) 2002-03-11
CA2380216C (en) 2012-01-31
CN1173736C (zh) 2004-11-03
MXPA02000838A (es) 2002-07-30
ES2186596T3 (es) 2007-11-16
DE60035049T2 (de) 2007-09-27
AU5843200A (en) 2001-02-13
HUP0202107A2 (en) 2002-10-28
EE200200032A (et) 2003-02-17
NO329827B1 (no) 2011-01-03
US20080003216A1 (en) 2008-01-03
SK287522B6 (sk) 2011-01-04
IL131047A0 (en) 2001-01-28
KR100682219B1 (ko) 2007-02-12
EA200200189A1 (ru) 2002-12-26
KR20020027493A (ko) 2002-04-13
BRPI0012675B8 (pl) 2021-05-25
US7741276B2 (en) 2010-06-22
EP1206274B1 (en) 2007-05-30
CZ302114B6 (cs) 2010-10-20
PL202477B1 (pl) 2009-06-30
EP1206274A2 (en) 2002-05-22
IL147675A (en) 2009-05-04
HK1048248A1 (en) 2003-03-28
NO20020153D0 (no) 2002-01-11
DE1206274T1 (de) 2002-11-14
TR200200169T2 (tr) 2002-06-21
DK1206274T3 (da) 2007-08-13
HK1048248B (zh) 2005-04-22
JP2003505472A (ja) 2003-02-12
CY1107932T1 (el) 2013-09-04
ATE363288T1 (de) 2007-06-15
UA73745C2 (en) 2005-09-15
BG106311A (en) 2002-08-30
EE04838B1 (et) 2007-06-15
WO2001007480A3 (en) 2001-05-10
AR024907A1 (es) 2002-10-30
BR0012675A (pt) 2002-04-09
WO2001007480A2 (en) 2001-02-01
CA2380216A1 (en) 2001-02-01
HUP0202107A3 (en) 2005-01-28

Similar Documents

Publication Publication Date Title
PL353732A1 (pl) Zastosowanie inhibitorów IL-18Zastosowanie inhibitorów IL-18
BG106242A (en) Metalloprotease inhibitors
AP2001002319A0 (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors.
SG148864A1 (en) Methods of treating cancer and related methods
IL145907A0 (en) Use of glucosylceramide synthesis inhibitors in therapy
AU2002340168A1 (en) Treatment of prostate cancer by inhibitors of ncam2
HUP0300061A3 (en) Use of il-18 inhibitors
UA66793C2 (uk) Лептин як стримувач швидкого збільшення пухлини клітини
EP0975353A4 (en) PEPTIDYL-2-AMINO-1HYDROXYALKANESULPHONIC ACIDS AS CYSTEIN PROTEASE INHIBITORS
SI1181294T1 (en) Novel derivatives and analogues of galanthamin
ZA200106197B (en) Use of glycogen phosphorlase inhibitors to inhibit tumor growth.
IL147748A0 (en) Use of etodolac to treat cancer
IL150125A0 (en) Novel compounds
AU2001246600A1 (en) Use of comt inhibitors as analgesics
EP1435941B8 (en) Wortmannin analogs and methods of using same
AU2003243381A8 (en) Variants of antithrombin iii
SG148860A1 (en) Stereospecific reduction of sapogen-3-ones
SI1206274T1 (sl) Uporaba zaviralcev interlevkina-18 za zaviranje tumorske metastaze
DE50311665D1 (de) Guanidinophenylalanin-verbindungen als urokinase-inhibitoren
ATE377586T1 (de) Tripeptidylpeptidaseinhibitoren
MXPA02008014A (es) Composiciones inhibidoras de tumores de 1-nitroacridina.
JO2055B1 (en) A device that prevents the illegal use of water
GR1003469B (el) Αντισεισμικο συστημα
CA96216S (en) Breast pad
AU147652S (en) Gutter member